Feinberg Cardiovascular Research Institute, Northwestern University Medical Center, Chicago, Ill 60611, USA.
Transl Res. 2010 Jan;155(1):27-34. doi: 10.1016/j.trsl.2009.09.007.
alpha- and beta-Adrenergic receptor agonists induce an inotropic response in the adult heart by promoting the phosphorylation of several regulatory proteins, including myosin-binding protein C (MyBP-C), cardiac troponin I (cTnI), and phospholamban (PLB). However, the adrenergic-induced phosphorylation of these proteins has not been characterized in the developing heart. Accordingly, we evaluated MyBP-C, cTnI, and PLB phosphorylation in cultured neonatal rat cardiomyocytes (NRCMs) after alpha- and beta-receptor activation with phenylephrine and isoproterenol. alpha-Receptor stimulation increased, whereas beta-receptor activation reduced MyBP-C phosphorylation. Isoelectric-focusing experiments indicated that the amount of monophosphorylated MyBP-C was sensitive to alpha-adrenergic activation, but diphosphorylated and triphosphorylated MyBP-C levels were largely unaffected. The phosphorylation of cTnI and PLB was consistent with the mechanism observed in adult hearts: alpha- and beta-Receptor stimulation phosphorylated both proteins. For cTnI, the greatest difference associated with beta-receptor activation was observed in the diphosphorylated state, whereas alpha-receptor activation was associated with a marked increase in the tetraphosphorylated protein and absence of the unphosphorylated state. Despite these apparent changes in cTnI and PLB phosphorylation, beta-receptor activation failed to alter calcium transients in NRCMs. Collectively, these findings suggest that, unlike cTnI and PLB, MyBP-C and inotropy are not coupled to beta-adrenergic stimulation in NRCMs. Therefore, cTnI and PLB probably play a more central role in modulating contractile function in NRCMs in response to catecholamines than does MyBP-C, and MyBP-C may have a structural role in stabilizing thick filament assembly rather than influencing cross-bridge formation in developing hearts.
α 和 β 肾上腺素能受体激动剂通过促进几种调节蛋白的磷酸化,包括肌球蛋白结合蛋白 C(MyBP-C)、心肌肌钙蛋白 I(cTnI)和磷酸化肌浆球蛋白结合蛋白(PLB),在成人心肌中诱导变力反应。然而,在发育心脏中尚未对这些蛋白的肾上腺素能诱导磷酸化进行表征。因此,我们评估了苯肾上腺素和异丙肾上腺素激活α 和 β 受体后培养的新生大鼠心肌细胞(NRCM)中 MyBP-C、cTnI 和 PLB 的磷酸化。α 受体刺激增加,而 β 受体激活减少 MyBP-C 磷酸化。等电聚焦实验表明,单磷酸化 MyBP-C 的量对α 肾上腺素能激活敏感,但二磷酸化和三磷酸化 MyBP-C 水平基本不受影响。cTnI 和 PLB 的磷酸化与在成人心脏中观察到的机制一致:α 和 β 受体刺激均磷酸化这两种蛋白。对于 cTnI,与β 受体激活相关的最大差异发生在二磷酸化状态,而α 受体激活与四磷酸化蛋白的显著增加和无磷酸化状态相关。尽管 cTnI 和 PLB 磷酸化发生了这些明显变化,但β 受体激活未能改变 NRCM 中的钙瞬变。总的来说,这些发现表明,与 cTnI 和 PLB 不同,MyBP-C 和变力性与 NRCM 中的β 肾上腺素能刺激不相关。因此,cTnI 和 PLB 可能在调节对儿茶酚胺的 NRCM 收缩功能方面比 MyBP-C 发挥更核心的作用,而 MyBP-C 可能在稳定粗丝组装而不是影响发育心脏中的横桥形成方面发挥结构作用。